Chief Financial Officer
Richard Taylor has over 35 years of experience in supporting biotechnology companies from a financial perspective. He spent 16 years with Syntex/Roche including Director of Finance for the Development Research division with an annual budget over $200M. He has spent the last 20 years as the CFO/senior finance officer with various start-up biotech and medical device companies. He has B.S. from the University of California-Berkeley in Biology, a M.S. in Biology from Stanford University and a MBA from the University of Chicago.